SFRP5 and metabolic dysfunction-associated steatohepatitis: Moreover, given that inflammation and ballooning are two of the main finding of NASH [20], we wanted to explore the SFRP5 abundance differences according to the presence or absence of inflammation (portal and lobular) and hepatic ballooning.